Vascular Biogenics Ltd.
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Vascular Biogenics Ltd.'s past years’ income statements indicate that its last revenue has decreased compared to the previous period by 14% to $658,000. Profit margin reached -4897%. Total operating expenses were $33,407,000.

Profit Margin

Vascular Biogenics Ltd. (NASDAQ:VBLT): Profit margin
2013 0 -17.37M
2014 0 -17.40M
2015 0 -14.88M
2016 0 -16.00M
2017 13.86M -10.13M -73.12%
2018 585K -20.45M -3497.09%
2019 562K -19.77M -3517.79%
2020 922K -24.33M -2638.83%
2021 768K -28.70M -3738.02%
2022 658K -32.21M -4896.5%

VBLT Income Statement (2013 – 2022)

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue
Revenue
658K768K922K562K585K13.86M0000
Cost of revenue
104K365K394K163K235K340K0000
Gross profit
554K403K528K399K350K13.52M0000
Operating exp.
Research and development
21.65M22.69M19.65M15.47M15.94M17.77M12.44M11.19M10.97M13.50M
Selling and marketing
0000397K562K0000
Total operating expenses
33.40M30.39M25.01M20.41M21.55M24.17M16.27M14.87M14.77M15.96M
Operating income
-32.85M-29.99M-24.48M-20.01M-21.20M-10.65M-16.27M-14.87M-14.77M-15.96M
Other income (expenses), net
549K76K258K557K-122K517K22K-17K-2.62M213K
Income before tax
-32.30M-29.92M-24.22M-19.45M-20.45M-10.13M-16.00M-14.88M-17.40M-17.37M
Income tax expense
-85K-1.21M105K313K-749K-517K-273K17K2.62M1.41M
Net income
-32.21M-28.70M-24.33M-19.77M-20.45M-10.13M-16.00M-14.88M-17.40M-17.37M
Earnings per share
Basic EPS
-0.42-0.41-0.56-0.55-0.62-0.37-0.64-0.73-3.09-1.44
Diluted EPS
-0.42-0.41-0.56-0.55-0.62-0.37-0.64-0.73-3.09-1.44
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source